Tempest Therapeutics (TPST) Institutional Ownership $10.51 -0.49 (-4.45%) Closing price 04:00 PM EasternExtended Trading$10.34 -0.17 (-1.67%) As of 06:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Tempest Therapeutics (NASDAQ:TPST)CurrentInstitutional OwnershipPercentage22.52%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$52.77MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$24.72M Get TPST Insider Trade Alerts Want to know when executives and insiders are buying or selling Tempest Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data TPST Institutional Buying and Selling by Quarter Tempest Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/11/2025 Versant Venture Management LLC269,772$1.83M2.2%-92.3%7.331% 8/8/2025 Geode Capital Management LLC34,736$236K0.0%-92.0%0.944% 2/17/2025Millennium Management LLC189,506$158K0.0%N/A0.434% 2/14/2025Jane Street Group LLC493,094$411K0.0%N/A1.130% 2/14/2025Northern Trust Corp67,815$57K0.0%+233.2%0.155% 2/13/2025XTX Topco Ltd160,807$134K0.0%+570.3%0.368% 2/12/2025Geode Capital Management LLC354,276$296K0.0%+61.0%0.812% 2/12/2025Versant Venture Management LLC3,507,055$2.93M3.4%N/A8.036% 2/11/2025Virtu Financial LLC43,105$36K0.0%N/A0.099% 11/16/2024Geode Capital Management LLC220,067$308K0.0%+42.7%0.873% Get the Latest News and Ratings for TPST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tempest Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024XTX Topco Ltd23,989$34K0.0%N/A0.095% 11/5/2024Empower Advisory Group LLC35,000$49K0.0%N/A0.139% 10/29/2024Fullcircle Wealth LLC62,000$87K0.0%N/A0.279% 8/9/2024Dimensional Fund Advisors LP25,084$55K0.0%N/A0.113% 5/20/2024Virtu Financial LLC28,574$112K0.0%+69.2%0.129% 2/15/2024MayTech Global Investments LLC10,000$44K0.0%N/A0.052% 8/14/2023Rock Springs Capital Management LP536,214$681K0.0%-34.9%4.026% 8/11/2023Sectoral Asset Management Inc.219,394$279K0.0%N/A1.893% 2/14/2022Maven Securities LTD77,377$409K0.0%-39.0%1.120% 11/15/2021Franklin Resources Inc.15,240$221K0.0%N/A0.227% 11/12/2021Renaissance Technologies LLC34,104$493K0.0%+26.9%0.509% 11/9/2021BlackRock Inc.82,698$1.20M0.0%+1,581.2%1.234% 11/9/2021Monashee Investment Management LLC60,000$868K0.2%-47.2%0.896% 8/18/2021Ikarian Capital LLC89,865$1.01M0.1%N/A7.076% 8/17/2021Boothbay Fund Management LLC10,477$117K0.0%N/A0.825% 8/16/2021Maven Securities LTD106,628$1.20M0.0%N/A8.396% 8/13/2021Renaissance Technologies LLC26,867$300K0.0%N/A2.116% 8/13/2021Knott David M13,833$155K0.1%N/A1.089% 8/13/2021Vanguard Group Inc.61,150$683K0.0%N/A4.815% 8/13/2021FMR LLC647,898$7.24M0.0%N/A51.016% 8/12/2021Monashee Investment Management LLC113,644$1.27M0.2%N/A8.948% (Data available from 1/1/2016 forward) TPST Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TPST shares? During the previous two years, 11 institutional investors and hedge funds held shares of Tempest Therapeutics. The most heavily invested institutionals were Versant Venture Management LLC ($1.83M), Jane Street Group LLC ($411K), Geode Capital Management LLC ($236K), Millennium Management LLC ($158K), XTX Topco Ltd ($134K), Fullcircle Wealth LLC ($87K), and Northern Trust Corp ($57K).Learn more on Tempest Therapeutics' institutional investors. What percentage of Tempest Therapeutics' stock is owned by institutional investors? 22.52% of Tempest Therapeutics' stock is owned by institutional investors. Learn more on TPST's institutional investor holdings. Which institutional investors have been buying Tempest Therapeutics' stock? Of the 11 institutional investors that purchased Tempest Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Versant Venture Management LLC ($3.51M), Jane Street Group LLC ($493.09K), Geode Capital Management LLC ($200.04K), Millennium Management LLC ($189.51K), XTX Topco Ltd ($160.81K), Fullcircle Wealth LLC ($62K), and Virtu Financial LLC ($54.79K). How much institutional buying is happening at Tempest Therapeutics? Institutional investors have bought a total of 4,738,063 shares in the last 24 months. This purchase volume represents approximately $52.77M in transactions. Which of Tempest Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Tempest Therapeutics stock in the last 24 months: Versant Venture Management LLC ($3.24M), and Geode Capital Management LLC ($398.61K). How much institutional selling is happening at Tempest Therapeutics? Institutional investors have sold a total of 3,635,893 shares in the last 24 months. This volume of shares sold represents approximately $24.72M in transactions. Related Companies DERM Major Shareholders ACTU Major Shareholders FTLF Major Shareholders CRBU Major Shareholders VTYX Major Shareholders ALTS Major Shareholders BTMD Major Shareholders CTOR Major Shareholders NVCT Major Shareholders MCRB Major Shareholders This page (NASDAQ:TPST) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredPOP QUIZ: What’s the #1 indicator of a stock’s success? (Nope, not earnings or sales)What indicator do you think is the #1 predictor of stock market success? Most would guess earnings or sales...The Oxford Club | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThis stock just surpassed PalantirThe media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempest Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tempest Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TPST Stock Alerts